In a recent webinar, Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain, Heather Munoz, Principal of Global Market Development, and James
South Texas Blood & Tissue COO recognized for exceptional leadership and contributions to donor services and transfusion medicine. Audra Taylor, Chief Operating Officer of South
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Honorees recognized by the San Antonio Business Journal reflect innovation, leadership and impact across BioBridge Global and its subsidiaries. Four members of BioBridge Global and
April marks National Donate Life Month, a time dedicated to encouraging Americans to register as organ, eye and tissue donors while honoring those who have
Emerging discoveries in blood group science highlight the need for advanced testing, donor diversity, and adaptable strategies across transfusion medicine and biotherapeutics. A new blood
Rohini Thevi Guntnur, Ray Rendon III, Joseph Higdon, Deidre Cacchillo, and Rogelio Zamilpa Therapeutic efficacy, reliability, and availability of cell, gene, and tissue-derived therapies have
BBG Advanced Therapies was recently highlighted in a GlobalData feature examining the emerging role of extracellular vesicles (EVs) in regenerative medicine and targeted drug delivery.
Heather Munoz discusses how blood center infrastructure and flexible collection models are supporting the continued growth of cell and gene therapy. Heather Munoz, principal, global
Program milestone highlights lifesaving impact of civilian prehospital whole blood in San Antonio and beyond On Thursday, Jan. 29, South Texas Blood & Tissue celebrated
Before sunrise on MLK Day, more than 50 BioBridge Global staff members gathered in downtown San Antonio to take part in the city’s annual MLK
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally